SlideShare a Scribd company logo
1 of 37
Incremental cost-effectiveness of
           preventing depression in at-risk
           adolescents
                   John Dickerson, MS
                   May 1, 2012
                   18th Annual HMO Research Network Conference,
                   Seattle, WA

© 2011, KAISER PERMANENTE CENTER FOR HEALTH RESEARCH
Frances L. Lynch, PhD
                                          John F. Dickerson, MS
                                             Greg Clarke, PhD
                                          V Robin Weersing, PhD
                                          William Beardslee, MD
                                             Lynn DeBar, PhD
                                        Tracey RG Gladstone, PhD
                                              David Brent MD
                                             Tami Mark, PhD
                                           Giovanna Porta, MS
                                            Judy Garber, PhD

© 2011, KAISER PERMANENTE CENTER FOR HEALTH RESEARCH
Acknowledgements


     Boston                                           Pittsburgh
               Rachel Ammirati                             Yuan Brustoloni     Satish Iyengar
               Jim Cooney                                  Brian McKain        Nadine Melhem
               Kate Ginnis                                 Deena Palenchar     Tim Pitts
               Mary Kate Little                            Jennifer Spendley   Ebony West
               Ellen Murachver                             Nathan Wigham       Jamie Zelazny
               Shula Ponet
               Phyllis Rothberg
               Carol Tee
                                                       Portland
     Nashville                                          
                                                         
                                                             Kristina Booker
                                                             Alison Firemark
               Mary Jo Coiro        Beth Donaghey          Bobbi Jo Yarborough
               Laurel Duncan        Liz Ezell              Stephanie Hertert
               Jocelyn Carter       Wendi Marien           Sue Leung
               Rachel Swan          Matt Morris            Tracy O’Connor
               Brandyn Street       Sarah Frankel          Kevin Rogers
               Katie Gallerani      Christian Webb         Jane Wallace
               Mi Wu


© 2011, KAISER PERMANENTE CENTER FOR HEALTH RESEARCH
Adolescent Depression


  Point prevalence rates of 3-8%
  Average age of first onset = 15 years
  Lifetime prevalence rate of depression by end of
   adolescence = 25%
  Relapse rate of 40% within 2 years; 75% within 5 years
  Symptoms of depression in adolescence are associated
   with risk for full-blown disorder
  Most cases of recurrent adult depression have initial
   onsets during adolescence
© 2011, KAISER PERMANENTE CENTER FOR HEALTH RESEARCH
Consequences of Adolescent Depression
     – Short Term
      Difficulties in relationships
      Impaired school and work performance
      Increased risk for teen pregnancy
      Increased risk for substance abuse
      Reduced quality of life
      Higher rates of suicide attempts
      Higher health care costs
      Greater use of school and other social services
© 2011, KAISER PERMANENTE CENTER FOR HEALTH RESEARCH
Consequences of Adolescent Depression
     – Long Term

       Poor functional outcomes in adulthood
       Reduced quality of life
       Higher rates of suicide attempts
       More psychiatric and medical hospitalizations
       Lower educational attainment
       More time out of work


© 2011, KAISER PERMANENTE CENTER FOR HEALTH RESEARCH
Risk Factors for Depression

      Parental Depression
             Increases risk of youth depression by 40%
      Sub-syndromal Depression symptoms
             Symptoms but not meeting diagnostic criteria
             Increases risk of youth depression by 30%
      Previous Episodes of Depression
            (Weisz et al. 2006; Birmaher & Brent 2007; TADS Team 2004; NICE 2008)



© 2011, KAISER PERMANENTE CENTER FOR HEALTH RESEARCH
Parental Depression


   Strongest risk factor for depression in youth
   4X greater risk of depression in children of depressed
    parents
   Amongst adolescents seeking services for depression
    most have parents with current mood disorders
   More internalizing and externalizing disorders,
    cognitive delays, academic and social difficulties
© 2011, KAISER PERMANENTE CENTER FOR HEALTH RESEARCH
Treatment of Adolescent Depression


      Evidence for pharmacotherapy and psychotherapy
       (interpersonal psychotherapy, cognitive-behavioral psychotherapy)
      Only 25% of youth who meet depression criteria
       receive any type of treatment
      50-60% of those treated in controlled research
       studies show improvement
      Current clinical practice fails to alleviate the majority
       of the disease burden associated with depression

© 2011, KAISER PERMANENTE CENTER FOR HEALTH RESEARCH
Prevention and Mental Health

           Clinical resources focused on current crises
           Researchers and clinicians trained in pathology-
            based models
           Insurance and health care systems designed to
            provide treatment of disease, prevention is typically
            less well funded
           Most insurance does not currently cover
            prevention services for mental health

© 2011, KAISER PERMANENTE CENTER FOR HEALTH RESEARCH
Studies evaluating prevention interventions

       Multiple RCT have demonstrated that it is possible
        to prevent depression episodes using
        psychotherapeutic interventions including CB
        approaches
       In particular, two studies have demonstrated that
        a CB Prevention intervention can reduce the risk
        of depression episodes in youth of depressed
        parents (Clarke et al. 2001; Lynch et al. 2005; Garber et al. 2010)

© 2011, KAISER PERMANENTE CENTER FOR HEALTH RESEARCH
Prevention of Depression (POD) Study
      Specific Aims


  To test the efficacy of a cognitive-behavioral (CB)
   program for preventing depression in at-risk
   adolescents, across 4 sites
  To explore possible moderators
  To examine cost-effectiveness of program
   compared to TAU


© 2011, KAISER PERMANENTE CENTER FOR HEALTH RESEARCH
Inclusion Criteria

  At least one biological parent had a current and/or
   past depressive episode
  Adolescents (13-17 years old) had
         Current subsyndromal symptoms of depression [CES-D > 20]
         A history of a diagnosed depressive disorder
         Or both

  Both a selective and indicated sample

© 2011, KAISER PERMANENTE CENTER FOR HEALTH RESEARCH
Exclusion Criteria

     Neither parent nor the teen could be bipolar or
      schizophrenic
     Teens could not
            currently meet criteria for MDD or dysthymia
            currently be taking any anti-depressant medication
            have received cognitive-behavioral therapy




© 2011, KAISER PERMANENTE CENTER FOR HEALTH RESEARCH
Study Design



              RCT
              4 sites (Nashville, TN; Boston, MA;
               Pittsburgh PA; Portland OR)
              Adolescents aged 13-17 years
              At-risk for depression
              316 youth participated in study

© 2011, KAISER PERMANENTE CENTER FOR HEALTH RESEARCH
POD Prevention Program

     •     Cognitive therapy approach
     •     Groups ranged in size from 3 to 10
     •     Mixed gender, expected 60-80% female
     •     8 weekly Acute sessions, 90 minute per session
     •     6 monthly Continuation sessions, also 90 min’s
     •     Parent group: weeks 1 and 8 (variable
           attendance)
     • Led by Master’s level therapists
© 2011, KAISER PERMANENTE CENTER FOR HEALTH RESEARCH
Methods


                 Participants assessed at baseline, 3, and 9
                  months blind to intervention status
                 Randomized to either CBP or UC
                 All participants could initiate or continue any
                  health care services, non-health services (e.g.,
                  school, social services)

© 2011, KAISER PERMANENTE CENTER FOR HEALTH RESEARCH
Clinical Outcome Measures


      Schedule for Affective Disorders and
       Schizophrenia for School- Age Children
       (KSADS) Present and Lifetime Version (Kaufman et al. 1997)
      Clinical Global Impression Scale (CGI) -
          Improvement (Guy 1976)
      Child Depression Rating Scale (CDRS) –Revised
          (Poznanski et al. 1994; Brent et al. 2008).


© 2011, KAISER PERMANENTE CENTER FOR HEALTH RESEARCH
Clinical Effects for the CEA


                  Depression Free Days (DFD)
                  Quality-adjusted Life Years (QALY)
                  Used clinical data at each assessment
                  Use linear interpolation between clinical
                   time points
                  Summed over 9 months

© 2011, KAISER PERMANENTE CENTER FOR HEALTH RESEARCH
Cost Data

         Comprehensive costs of interventions, usual
          care across service sectors, parent time costs
         Collected concurrent with trial
         Sources of data
               Interviews with study personnel
               Study activity and financial records
               Child and Adolescent Services Assessment (CASA)
                     Parent and youth report


© 2011, KAISER PERMANENTE CENTER FOR HEALTH RESEARCH
Types of Cost Included


            • Interventions
                  – CBP
                  – Including training and supervision
            • Usual Care health care
                   General medical and mental health specialty

            • Comprehensive services outside Health
                   Including school, social services, juvenile justice

            • Family costs
                   Time, travel


© 2011, KAISER PERMANENTE CENTER FOR HEALTH RESEARCH
Valuation of resources

              Study financial records
             • Estimated cost of Usual Care services
                    • Unit costs from large databases including MEPS,
                      Marketscan Claims Databases, Previous Studies
                                             (Lynch et al. 2005; Lynch et al. 2011; Domino et al. 2008)


             • Parent and participant reported costs for outside
               health and other costs
             • Estimated parent time costs using human capital
               approach
             • All resources in 2009 $
© 2011, KAISER PERMANENTE CENTER FOR HEALTH RESEARCH
Statistical Analyses


      Analyses were intention-to-treat basis

      Hypotheses tests from based on group variable in OLS regression
       models

      Bootstrapping with a single model with 1000 replications
         (BCa; Thompson et al. 2000; O’Brien & Briggs 2002; O’Brien et al. 1994).


      Net benefit regression framework to estimate
             Cost Effectiveness Acceptability Curve (CEAC)
             Examine differential CE for subgroups indicated by primary clinical analyses
                 (Hoch et al. 2005)



© 2011, KAISER PERMANENTE CENTER FOR HEALTH RESEARCH
Analyses


                  Main
                         All randomized youth
                  Sensitivity
                         Alternative QALY weights
                         Removal of outliers
                  Sub-group analyses
                         Based on clinical moderation analyses
                               Youth whose parents were actively depressed at baseline



© 2011, KAISER PERMANENTE CENTER FOR HEALTH RESEARCH
Missing Data


      Complete clinical outcome and health services data on 87%
       of participants
      Multiple imputation with chained equations (Royston 2004; Royston
          2005) using STATA

      Assumed missing at random
      Included all non-missing values at all time points and
       baseline demographics in the models
      Created five imputation datasets (Little & Rubin 2002)

© 2011, KAISER PERMANENTE CENTER FOR HEALTH RESEARCH
Table 1 – Sample Description
                                       CBP                TAU             p


Adolescents (N=316)                           n=159             n=157


    Age                                      14.8 (1.5)     14.8 (1.3)   .66

    Female                               93 (58.5%)        92 (58.6%)    .98

   Caucasian                             129 (82.7%)       125 (80.6%)   .64

   Latino/Hispanic                           10 (6.3%)      11 (7.1%)    .78

CES-D (entry qualifying score)               18.5 (9.1)     18.8 (9.6)   .83

Children’s Depression Rating Scale -
                                             28.6 (8.0)     29.1 (8.5)   .52
Revised

Household Income                         81 (52.3%)        96 (63.6%)    .045
Incremental Differences in Clinical
     Outcomes at 9 months

              CBP group had:


                     13 more DFDs (p=.008)
                     0.022 more QALYs (p=.008)
                     DFD increased over time for both
                      groups

© 2011, KAISER PERMANENTE CENTER FOR HEALTH RESEARCH
Table 3. Service Use thru 9 months
                                         % with any use              Mean use (SD)
                                         CBP       TAU           CBP                 TAU
Inpatient Mental Health Days               1.9            1.3    33.3 (46.5)         11.0 (9.9)
Inpatient Alcohol or Drug Days             1.3             0     24.0 (28.3)
Counseling or Medication Visits           29.6       27.4        11.3 (17.3)         9.1 (14.3)
Day Hospital Days                          0.6             0        106 (--)
Alcohol or Drug Treatment Visits           1.3            0.6      8.5 (6.4)          33.0 (--)
Crisis Services                            2.5            0.6    24.0 (34.5)           2.0 (--)
Medical doctor visits                      6.3       11.5          2.1 (1.5)          1.8 (1.1)
Emergency Room Visits                      1.9            1.3          1 (--)         2.5 (2.1)
                                           5.7            5.1
Days of Antidepressant Medication                               110.9 (78.7)    126.0 (86.5)
                                           3.1            1.9
Days of Stimulant Medication                                    105.6 (74.2)     61.0 (30.0)

Days of Other Psych Medication             0.0            1.3    73.0 (70.4)         153.0 (--)

ANY School Services                       20.1       22.9        29.1 (61.1)    44.9 (105.2)

Juvenile correction contact                1.3            3.2     10.0 (2.8)          5.2 (7.3)
Table 4. Cost (2009 USD) thru 9 months


                            CBP     TAU        CBP           TAU

 Non-Protocol Costs
% with Any Cost/
Mean Cost (SD)               52.1   50.3     882 (3,285)   740 (2,021)

Family Costs                 38.2   36.9        55 (170)     109 (470)

 Intervention Costs
CBP Program Costs                              277 (108)

Intervention Family costs                      314 (200)

Total Intervention Costs                       591 (286)

TOTAL COST                                 1,579 (4,073)   802 (2,126)
Table 5: Adjusted cost effectiveness ratios
                                                                            ICER (95% CI)*
                                                                  DFD                  QALY

Full Sample (n=316)                                                59                  35,434
                                                                (11 -263)         (6,350 – 157,594)

Conservative QALY weight [70%]                                     NA                  47,250
                                                                                  (8,706 – 210,125)

Excluding cost outlier (n=315)                                     34                  20,417
                                                                (2 – 125)         (1,193 – 75,188)

Excluding patients with ANY                                         20                 12,267
                                                                 (-1– 76)          (-751 –45,581)
inpatient utilization (n=308)
Outpatient costs only (n=316)                                      44                  26,618
                                                                (7 – 192)         (4,063 – 115,461)

Parental depression**                                           Dominated            Dominated

No parental depression                                             14                  8,683
                                                                (-7 – 42)         (-4,157–25,156)


   *. bias corrected; **. CBP never preferred for this group.
Figure 1. Cost-effectiveness Planes Base Case

                                                                     CDRS-DFDs -- through month 8
                             $2,000




                                                                                                                                       Higher cost, better outcome
                                        Higher cost, worse outcome
    Incremental Total Cost
                             $1,000
                             $0
                             -$1,000
                             -$2,000




                                         Lower cost, worse outcome                                                                     Lower cost, better outcome


                                       -40            -30            -20            -10             0              10             20               30                40

                                                                        Incremental Change in CDRS-DFD
                                       1000 replications; adjusted for age, baseline costs, race, household income, and gender differences
© 2011, KAISER PERMANENTE CENTER FOR HEALTH RESEARCH
Figure 2. Cost-effectiveness acceptability curve base case

                                                                           QALY (CDRS-DFD-based) at Month 8
                                               100%
     Probability Treatment is Cost-Effective
                                               75%
                                               50%
                                               25%
                                               0%




                                                      $0   $50,000   $100,000   $150,000   $200,000      $300,000   $400,000   $500,000
                                                                                            Willingness to Pay
© 2011, KAISER PERMANENTE CENTER FOR HEALTH RESEARCH
Figure 3. Cost-effectiveness planes by subgroup

                                                 No Parental Depression at Baseline                                                                                                          Parental Depression at Baseline




                                                                                                                                                                      $4,000
                             $4,000




                                          Higher cost, worse outcome                                                                                                              Higher cost, worse outcome                                        Higher cost, better outcome
                                                                                                          Higher cost, better outcome




                                                                                                                                                                      $2,000
                             $2,000
    Incremental Total Cost




                                                                                                                                             Incremental Total Cost
                                                                                                                                                                      $1,000
                             $1,000




                                                                                                                                                                      $0
                             $0




                                                                                                                                                                      -$1,000
                             -$1,000




                                                                                                                                                                      -$2,000
                             -$2,000




                                                                                                          Lower cost, better outcome                                                                                                                 Lower cost, better outcome
                                                                                                                                                                                  Lower cost, worse outcome
                             =$4,000




                                                                                                                                                                      =$4,000




                                         Lower cost, worse outcome


                                       -40      -30       -20       -10        0        10       20        30        40                                                         -40        -30        -20        -10         0         10         20         30         40

                                                        Incremental Change in CDRS-DFD                                                                                                           Incremental Change in CDRS-DFD
                                       1000 replications; adjusted for age, baseline costs, race, household income, and gender differences                                      1000 replications; adjusted for age, baseline costs, race, household income, and gender differences


© 2011, KAISER PERMANENTE CENTER FOR HEALTH RESEARCH
Figure 4.       Cost-effectiveness acceptability curves by subgroup

                                                             No Parental Depression at Baseline                                                                                       Parental Depression at Baseline
                                   100%




                                                                                                                                                           100%
                                                                                                                                                           75%
                                   75%
Probability Treatment is Cost-Effective




                                                                                                                        Probability Treatment is Cost-Effective
                                                                                                                                                           50%
                                   50%




                                                                                                                                                           25%
                                   25%
                                   0%




                                                                                                                                                           0%




                                            $0   $50,000 $100,000 $150,000 $200,000    $300,000   $400,000   $500,000                                             $0   $50,000 $100,000 $150,000 $200,000    $300,000   $400,000   $500,000
                                                                           Willingness to Pay                                                                                                    Willingness to Pay
© 2011, KAISER PERMANENTE CENTER FOR HEALTH RESEARCH
Preliminary Conclusions

        CBP increased DFD and QALYs
        CBP significantly more expensive
        CBP is very likely to be cost-effective compared to
         many medical services currently covered by most
         insurance programs
        CBP highly cost-effective for youth whose parent’s
         depression was in REMISSION at baseline

© 2011, KAISER PERMANENTE CENTER FOR HEALTH RESEARCH
Limitations


              Did not include productivity costs for youth
                     Adult literature suggests productivity is the largest cost of depression
                     Suggests substantial lost time from school
              Did not include all family costs
                     Included typical parent time costs
                     Did NOT include caregiving time, coordination, other
              Methods for calculating QALYs
                     Followed standard methods, but did not directly measure utility weights
                     No utility weights in youth available – used adult weights
                     Weights do not account for comorbidity


© 2011, KAISER PERMANENTE CENTER FOR HEALTH RESEARCH
Future Directions


      Replication over longer period of time
             Clinical outcomes and costs may change over time
             Data are collected through 32 months

      Need better information on sub-groups
             Larger sample could help to understand moderation of clinical and cost
              outcomes
             May need to adapt interventions for some risk groups
                      Co-treatment of parent and youth, sequential treatment of parent and youth


      Need for Preference Based HRQL in youth
             Evidence that depression negatively affects HRQL in youth
             No preference based QALY weights for youth

© 2011, KAISER PERMANENTE CENTER FOR HEALTH RESEARCH

More Related Content

What's hot

ISPCAN Jamaica 2018 - Personality-targeted Interventions for Building Resilie...
ISPCAN Jamaica 2018 - Personality-targeted Interventions for Building Resilie...ISPCAN Jamaica 2018 - Personality-targeted Interventions for Building Resilie...
ISPCAN Jamaica 2018 - Personality-targeted Interventions for Building Resilie...Christine Wekerle
 
MHCC & ASCA co-presentation THEMHS 2011. Trauma Informed Care & Practice: Usi...
MHCC & ASCA co-presentation THEMHS 2011. Trauma Informed Care & Practice: Usi...MHCC & ASCA co-presentation THEMHS 2011. Trauma Informed Care & Practice: Usi...
MHCC & ASCA co-presentation THEMHS 2011. Trauma Informed Care & Practice: Usi...mhcc
 
Beverley Raphael-presentation
Beverley Raphael-presentationBeverley Raphael-presentation
Beverley Raphael-presentationmhcc
 
Challenges in Conducting a Clinical Trials in Comparing Treatments for Adoles...
Challenges in Conducting a Clinical Trials in Comparing Treatments for Adoles...Challenges in Conducting a Clinical Trials in Comparing Treatments for Adoles...
Challenges in Conducting a Clinical Trials in Comparing Treatments for Adoles...Eating Recovery Center
 
Presentatie eetstoornissen escap 2015 m5 beate herpertz_dahlmann_new_developm...
Presentatie eetstoornissen escap 2015 m5 beate herpertz_dahlmann_new_developm...Presentatie eetstoornissen escap 2015 m5 beate herpertz_dahlmann_new_developm...
Presentatie eetstoornissen escap 2015 m5 beate herpertz_dahlmann_new_developm...Utrecht
 
WOMEN IN MIND KEYNOTE: Everybody Hurts: The personal and political ramificati...
WOMEN IN MIND KEYNOTE: Everybody Hurts: The personal and political ramificati...WOMEN IN MIND KEYNOTE: Everybody Hurts: The personal and political ramificati...
WOMEN IN MIND KEYNOTE: Everybody Hurts: The personal and political ramificati...The Royal Mental Health Centre
 
S5 jan buitelaar_adhd_asd_overlap
S5 jan buitelaar_adhd_asd_overlapS5 jan buitelaar_adhd_asd_overlap
S5 jan buitelaar_adhd_asd_overlapUtrecht
 
Presentatie psychiose escap 2015 m2 celso arango_escap_final
Presentatie psychiose escap 2015 m2 celso arango_escap_finalPresentatie psychiose escap 2015 m2 celso arango_escap_final
Presentatie psychiose escap 2015 m2 celso arango_escap_finalUtrecht
 
iCAAD London 2019 - Dr Alberto Pertusa - Addiction treatment: What new medica...
iCAAD London 2019 - Dr Alberto Pertusa - Addiction treatment: What new medica...iCAAD London 2019 - Dr Alberto Pertusa - Addiction treatment: What new medica...
iCAAD London 2019 - Dr Alberto Pertusa - Addiction treatment: What new medica...iCAADEvents
 
Dissociative Identity Disorder Theories and Treatments
Dissociative Identity Disorder Theories and TreatmentsDissociative Identity Disorder Theories and Treatments
Dissociative Identity Disorder Theories and TreatmentsJennifer Espenschied
 
53770916
5377091653770916
53770916ahooooy
 
The Childhood Adversities Narrative (CAN)
The Childhood Adversities Narrative (CAN)The Childhood Adversities Narrative (CAN)
The Childhood Adversities Narrative (CAN)Parisa Kaliush
 
Fricchione psychosomatic medicine in mental health
Fricchione psychosomatic medicine in mental healthFricchione psychosomatic medicine in mental health
Fricchione psychosomatic medicine in mental healthjasonharlow
 
Caring for all in the last year of life: making a difference.
Caring for all in the last year of life: making a difference.Caring for all in the last year of life: making a difference.
Caring for all in the last year of life: making a difference.Bruce Mason
 
Opportunities to change the outcomes of traumatized children
Opportunities to change the outcomes of traumatized childrenOpportunities to change the outcomes of traumatized children
Opportunities to change the outcomes of traumatized childrenParisa Kaliush
 
Final%20 submission%20of%20non suicidal%20self-injury%20project
Final%20 submission%20of%20non suicidal%20self-injury%20projectFinal%20 submission%20of%20non suicidal%20self-injury%20project
Final%20 submission%20of%20non suicidal%20self-injury%20projectA.J. Panneton
 
Trauma-Informed Care, November 2011
Trauma-Informed Care, November 2011Trauma-Informed Care, November 2011
Trauma-Informed Care, November 2011Nancy J. Smyth, PhD
 

What's hot (20)

ISPCAN Jamaica 2018 - Personality-targeted Interventions for Building Resilie...
ISPCAN Jamaica 2018 - Personality-targeted Interventions for Building Resilie...ISPCAN Jamaica 2018 - Personality-targeted Interventions for Building Resilie...
ISPCAN Jamaica 2018 - Personality-targeted Interventions for Building Resilie...
 
MHCC & ASCA co-presentation THEMHS 2011. Trauma Informed Care & Practice: Usi...
MHCC & ASCA co-presentation THEMHS 2011. Trauma Informed Care & Practice: Usi...MHCC & ASCA co-presentation THEMHS 2011. Trauma Informed Care & Practice: Usi...
MHCC & ASCA co-presentation THEMHS 2011. Trauma Informed Care & Practice: Usi...
 
Beverley Raphael-presentation
Beverley Raphael-presentationBeverley Raphael-presentation
Beverley Raphael-presentation
 
HMRI Searcher Newsletter Winter 2012
HMRI Searcher Newsletter Winter 2012HMRI Searcher Newsletter Winter 2012
HMRI Searcher Newsletter Winter 2012
 
Challenges in Conducting a Clinical Trials in Comparing Treatments for Adoles...
Challenges in Conducting a Clinical Trials in Comparing Treatments for Adoles...Challenges in Conducting a Clinical Trials in Comparing Treatments for Adoles...
Challenges in Conducting a Clinical Trials in Comparing Treatments for Adoles...
 
Presentatie eetstoornissen escap 2015 m5 beate herpertz_dahlmann_new_developm...
Presentatie eetstoornissen escap 2015 m5 beate herpertz_dahlmann_new_developm...Presentatie eetstoornissen escap 2015 m5 beate herpertz_dahlmann_new_developm...
Presentatie eetstoornissen escap 2015 m5 beate herpertz_dahlmann_new_developm...
 
WOMEN IN MIND KEYNOTE: Everybody Hurts: The personal and political ramificati...
WOMEN IN MIND KEYNOTE: Everybody Hurts: The personal and political ramificati...WOMEN IN MIND KEYNOTE: Everybody Hurts: The personal and political ramificati...
WOMEN IN MIND KEYNOTE: Everybody Hurts: The personal and political ramificati...
 
S5 jan buitelaar_adhd_asd_overlap
S5 jan buitelaar_adhd_asd_overlapS5 jan buitelaar_adhd_asd_overlap
S5 jan buitelaar_adhd_asd_overlap
 
Trauma Informed Care: Theory & Pactice with Laurie Robinson
Trauma Informed Care: Theory & Pactice with Laurie RobinsonTrauma Informed Care: Theory & Pactice with Laurie Robinson
Trauma Informed Care: Theory & Pactice with Laurie Robinson
 
Schizophrenia
SchizophreniaSchizophrenia
Schizophrenia
 
Presentatie psychiose escap 2015 m2 celso arango_escap_final
Presentatie psychiose escap 2015 m2 celso arango_escap_finalPresentatie psychiose escap 2015 m2 celso arango_escap_final
Presentatie psychiose escap 2015 m2 celso arango_escap_final
 
iCAAD London 2019 - Dr Alberto Pertusa - Addiction treatment: What new medica...
iCAAD London 2019 - Dr Alberto Pertusa - Addiction treatment: What new medica...iCAAD London 2019 - Dr Alberto Pertusa - Addiction treatment: What new medica...
iCAAD London 2019 - Dr Alberto Pertusa - Addiction treatment: What new medica...
 
Dissociative Identity Disorder Theories and Treatments
Dissociative Identity Disorder Theories and TreatmentsDissociative Identity Disorder Theories and Treatments
Dissociative Identity Disorder Theories and Treatments
 
53770916
5377091653770916
53770916
 
The Childhood Adversities Narrative (CAN)
The Childhood Adversities Narrative (CAN)The Childhood Adversities Narrative (CAN)
The Childhood Adversities Narrative (CAN)
 
Fricchione psychosomatic medicine in mental health
Fricchione psychosomatic medicine in mental healthFricchione psychosomatic medicine in mental health
Fricchione psychosomatic medicine in mental health
 
Caring for all in the last year of life: making a difference.
Caring for all in the last year of life: making a difference.Caring for all in the last year of life: making a difference.
Caring for all in the last year of life: making a difference.
 
Opportunities to change the outcomes of traumatized children
Opportunities to change the outcomes of traumatized childrenOpportunities to change the outcomes of traumatized children
Opportunities to change the outcomes of traumatized children
 
Final%20 submission%20of%20non suicidal%20self-injury%20project
Final%20 submission%20of%20non suicidal%20self-injury%20projectFinal%20 submission%20of%20non suicidal%20self-injury%20project
Final%20 submission%20of%20non suicidal%20self-injury%20project
 
Trauma-Informed Care, November 2011
Trauma-Informed Care, November 2011Trauma-Informed Care, November 2011
Trauma-Informed Care, November 2011
 

Viewers also liked

Facts About Teen Depression
Facts About Teen Depression Facts About Teen Depression
Facts About Teen Depression Katherine Wolpert
 
Teen Depression - Symptoms, help a friend, case studies, teen depression in S...
Teen Depression - Symptoms, help a friend, case studies, teen depression in S...Teen Depression - Symptoms, help a friend, case studies, teen depression in S...
Teen Depression - Symptoms, help a friend, case studies, teen depression in S...elinaoldhoff
 
Input output , heat rate characteristics and Incremental cost
Input output , heat rate characteristics and Incremental costInput output , heat rate characteristics and Incremental cost
Input output , heat rate characteristics and Incremental costEklavya Sharma
 
Teen depression project
Teen depression projectTeen depression project
Teen depression projectjalissamarie
 
Teen depression awareness
Teen depression awareness Teen depression awareness
Teen depression awareness Flora A'Fowsh
 
Teen Depression: A Common, Treatable Condition
Teen Depression: A Common, Treatable ConditionTeen Depression: A Common, Treatable Condition
Teen Depression: A Common, Treatable ConditionSummit Health
 
Teenage depression
Teenage depressionTeenage depression
Teenage depressionRajesh V
 
Teenage Depression
Teenage DepressionTeenage Depression
Teenage Depressionksisler
 
The problems of teenagers
The problems of teenagersThe problems of teenagers
The problems of teenagersTeacherIam
 
Teen problems
Teen problemsTeen problems
Teen problemsmarinosa
 

Viewers also liked (15)

Cost....
Cost....Cost....
Cost....
 
Facts About Teen Depression
Facts About Teen Depression Facts About Teen Depression
Facts About Teen Depression
 
Teen issues
Teen issuesTeen issues
Teen issues
 
Teen depression
Teen depressionTeen depression
Teen depression
 
Teen Depression - Symptoms, help a friend, case studies, teen depression in S...
Teen Depression - Symptoms, help a friend, case studies, teen depression in S...Teen Depression - Symptoms, help a friend, case studies, teen depression in S...
Teen Depression - Symptoms, help a friend, case studies, teen depression in S...
 
Input output , heat rate characteristics and Incremental cost
Input output , heat rate characteristics and Incremental costInput output , heat rate characteristics and Incremental cost
Input output , heat rate characteristics and Incremental cost
 
Teen depression project
Teen depression projectTeen depression project
Teen depression project
 
Teen depression awareness
Teen depression awareness Teen depression awareness
Teen depression awareness
 
Teen depression
Teen depressionTeen depression
Teen depression
 
Teen Depression: A Common, Treatable Condition
Teen Depression: A Common, Treatable ConditionTeen Depression: A Common, Treatable Condition
Teen Depression: A Common, Treatable Condition
 
Adolescent Depression
Adolescent DepressionAdolescent Depression
Adolescent Depression
 
Teenage depression
Teenage depressionTeenage depression
Teenage depression
 
Teenage Depression
Teenage DepressionTeenage Depression
Teenage Depression
 
The problems of teenagers
The problems of teenagersThe problems of teenagers
The problems of teenagers
 
Teen problems
Teen problemsTeen problems
Teen problems
 

Similar to Incremental Cost Effectiveness of Preventing Depression in At Risk Adolescents DICKERSON

Conferencia de la Dra. Joanne Wolfe sobre Cuidados Paliativos Pediátricos, en...
Conferencia de la Dra. Joanne Wolfe sobre Cuidados Paliativos Pediátricos, en...Conferencia de la Dra. Joanne Wolfe sobre Cuidados Paliativos Pediátricos, en...
Conferencia de la Dra. Joanne Wolfe sobre Cuidados Paliativos Pediátricos, en...PrincipitoJuanPi
 
Stewart is2
Stewart is2Stewart is2
Stewart is2ECPP2014
 
Introduction to Palliative Nursing Care
Introduction to Palliative Nursing Care Introduction to Palliative Nursing Care
Introduction to Palliative Nursing Care Duangrat Monthaisong
 
MedicalResearch.com: Medical Research Exclusive Interviews July 16 2015
MedicalResearch.com:  Medical Research Exclusive Interviews July 16 2015MedicalResearch.com:  Medical Research Exclusive Interviews July 16 2015
MedicalResearch.com: Medical Research Exclusive Interviews July 16 2015Marie Benz MD FAAD
 
genetic counselling and role of nurse in genetic counselling
genetic counselling and role of nurse in genetic counsellinggenetic counselling and role of nurse in genetic counselling
genetic counselling and role of nurse in genetic counsellingpoonambiswas4
 
Third Annual Early Age Onset Colorectal Cancer Symposium - Finding The Ideal ...
Third Annual Early Age Onset Colorectal Cancer Symposium - Finding The Ideal ...Third Annual Early Age Onset Colorectal Cancer Symposium - Finding The Ideal ...
Third Annual Early Age Onset Colorectal Cancer Symposium - Finding The Ideal ...Colon Cancer Challenge Foundation
 
TickiT: an eHealth solution to the "Don't Ask, Don't Tell" face to face clini...
TickiT: an eHealth solution to the "Don't Ask, Don't Tell" face to face clini...TickiT: an eHealth solution to the "Don't Ask, Don't Tell" face to face clini...
TickiT: an eHealth solution to the "Don't Ask, Don't Tell" face to face clini...YTH
 
14a haase roll 2010 texas aya conference handouts
14a haase roll 2010 texas aya conference handouts14a haase roll 2010 texas aya conference handouts
14a haase roll 2010 texas aya conference handoutsMethodist HealthcareSA
 
Adverse Childhood Experiences: What We Know About Tennessee
Adverse Childhood Experiences: What We Know About TennesseeAdverse Childhood Experiences: What We Know About Tennessee
Adverse Childhood Experiences: What We Know About TennesseeHealth Easy Peasy
 
Copy of HRMC NCCAN 8.16 FINAL
Copy of HRMC NCCAN 8.16 FINALCopy of HRMC NCCAN 8.16 FINAL
Copy of HRMC NCCAN 8.16 FINALErika Panek
 
Emotional Health and Foster Care Adolescents
Emotional Health and Foster Care AdolescentsEmotional Health and Foster Care Adolescents
Emotional Health and Foster Care AdolescentsSarah Parks
 
Research proposal emotional health and foster care adolescents
Research proposal emotional health and foster care adolescentsResearch proposal emotional health and foster care adolescents
Research proposal emotional health and foster care adolescentsKaren McWaters
 
ISPCAN Jamaica 2018 (CIHRTeamSV) - Improving Health and Behavioral Outcomes a...
ISPCAN Jamaica 2018 (CIHRTeamSV) - Improving Health and Behavioral Outcomes a...ISPCAN Jamaica 2018 (CIHRTeamSV) - Improving Health and Behavioral Outcomes a...
ISPCAN Jamaica 2018 (CIHRTeamSV) - Improving Health and Behavioral Outcomes a...Christine Wekerle
 
Helen presentation for upload
Helen presentation for uploadHelen presentation for upload
Helen presentation for uploadveronicawain65
 

Similar to Incremental Cost Effectiveness of Preventing Depression in At Risk Adolescents DICKERSON (20)

Conferencia de la Dra. Joanne Wolfe sobre Cuidados Paliativos Pediátricos, en...
Conferencia de la Dra. Joanne Wolfe sobre Cuidados Paliativos Pediátricos, en...Conferencia de la Dra. Joanne Wolfe sobre Cuidados Paliativos Pediátricos, en...
Conferencia de la Dra. Joanne Wolfe sobre Cuidados Paliativos Pediátricos, en...
 
Childhood Cancer Symposium: Cancer's Impact on Families
Childhood Cancer Symposium: Cancer's Impact on FamiliesChildhood Cancer Symposium: Cancer's Impact on Families
Childhood Cancer Symposium: Cancer's Impact on Families
 
Stewart is2
Stewart is2Stewart is2
Stewart is2
 
Introduction to Palliative Nursing Care
Introduction to Palliative Nursing Care Introduction to Palliative Nursing Care
Introduction to Palliative Nursing Care
 
MedicalResearch.com: Medical Research Exclusive Interviews July 16 2015
MedicalResearch.com:  Medical Research Exclusive Interviews July 16 2015MedicalResearch.com:  Medical Research Exclusive Interviews July 16 2015
MedicalResearch.com: Medical Research Exclusive Interviews July 16 2015
 
genetic counselling and role of nurse in genetic counselling
genetic counselling and role of nurse in genetic counsellinggenetic counselling and role of nurse in genetic counselling
genetic counselling and role of nurse in genetic counselling
 
Session 5.4: Moody
Session 5.4: MoodySession 5.4: Moody
Session 5.4: Moody
 
Session 5.4: Moody
Session 5.4: MoodySession 5.4: Moody
Session 5.4: Moody
 
Session 5.4 Moody
Session 5.4 MoodySession 5.4 Moody
Session 5.4 Moody
 
05.4 moody pc
05.4 moody pc05.4 moody pc
05.4 moody pc
 
Third Annual Early Age Onset Colorectal Cancer Symposium - Finding The Ideal ...
Third Annual Early Age Onset Colorectal Cancer Symposium - Finding The Ideal ...Third Annual Early Age Onset Colorectal Cancer Symposium - Finding The Ideal ...
Third Annual Early Age Onset Colorectal Cancer Symposium - Finding The Ideal ...
 
TickiT: an eHealth solution to the "Don't Ask, Don't Tell" face to face clini...
TickiT: an eHealth solution to the "Don't Ask, Don't Tell" face to face clini...TickiT: an eHealth solution to the "Don't Ask, Don't Tell" face to face clini...
TickiT: an eHealth solution to the "Don't Ask, Don't Tell" face to face clini...
 
14a haase roll 2010 texas aya conference handouts
14a haase roll 2010 texas aya conference handouts14a haase roll 2010 texas aya conference handouts
14a haase roll 2010 texas aya conference handouts
 
Adverse Childhood Experiences: What We Know About Tennessee
Adverse Childhood Experiences: What We Know About TennesseeAdverse Childhood Experiences: What We Know About Tennessee
Adverse Childhood Experiences: What We Know About Tennessee
 
Copy of HRMC NCCAN 8.16 FINAL
Copy of HRMC NCCAN 8.16 FINALCopy of HRMC NCCAN 8.16 FINAL
Copy of HRMC NCCAN 8.16 FINAL
 
Emotional Health and Foster Care Adolescents
Emotional Health and Foster Care AdolescentsEmotional Health and Foster Care Adolescents
Emotional Health and Foster Care Adolescents
 
Research proposal emotional health and foster care adolescents
Research proposal emotional health and foster care adolescentsResearch proposal emotional health and foster care adolescents
Research proposal emotional health and foster care adolescents
 
ISPCAN Jamaica 2018 (CIHRTeamSV) - Improving Health and Behavioral Outcomes a...
ISPCAN Jamaica 2018 (CIHRTeamSV) - Improving Health and Behavioral Outcomes a...ISPCAN Jamaica 2018 (CIHRTeamSV) - Improving Health and Behavioral Outcomes a...
ISPCAN Jamaica 2018 (CIHRTeamSV) - Improving Health and Behavioral Outcomes a...
 
Work Life Balance
Work Life BalanceWork Life Balance
Work Life Balance
 
Helen presentation for upload
Helen presentation for uploadHelen presentation for upload
Helen presentation for upload
 

More from HMO Research Network

New Rules Dealing with Conflicts of Interest in Public Health Service Funded ...
New Rules Dealing with Conflicts of Interest in Public Health Service Funded ...New Rules Dealing with Conflicts of Interest in Public Health Service Funded ...
New Rules Dealing with Conflicts of Interest in Public Health Service Funded ...HMO Research Network
 
Evaluation of the Validity of the Gestational Length Assumptions Based Upon A...
Evaluation of the Validity of the Gestational Length Assumptions Based Upon A...Evaluation of the Validity of the Gestational Length Assumptions Based Upon A...
Evaluation of the Validity of the Gestational Length Assumptions Based Upon A...HMO Research Network
 
Comparative Safety of Infliximaband Etanercept on the Risk of Serious Infecti...
Comparative Safety of Infliximaband Etanercept on the Risk of Serious Infecti...Comparative Safety of Infliximaband Etanercept on the Risk of Serious Infecti...
Comparative Safety of Infliximaband Etanercept on the Risk of Serious Infecti...HMO Research Network
 
A Multi State Markov Model for Analyzing Patterns of Use of Opiod Treatments ...
A Multi State Markov Model for Analyzing Patterns of Use of Opiod Treatments ...A Multi State Markov Model for Analyzing Patterns of Use of Opiod Treatments ...
A Multi State Markov Model for Analyzing Patterns of Use of Opiod Treatments ...HMO Research Network
 
A Descriptive Study of Vaccinations Occuring During Pregnancy HENNINGER
A Descriptive Study of Vaccinations Occuring During Pregnancy HENNINGERA Descriptive Study of Vaccinations Occuring During Pregnancy HENNINGER
A Descriptive Study of Vaccinations Occuring During Pregnancy HENNINGERHMO Research Network
 
The Use of Administrative Data and Natural Language Processing to Estimate th...
The Use of Administrative Data and Natural Language Processing to Estimate th...The Use of Administrative Data and Natural Language Processing to Estimate th...
The Use of Administrative Data and Natural Language Processing to Estimate th...HMO Research Network
 
Patient Views of KRAS Testing for Treatment of Metastatic Colorectal Cancer L...
Patient Views of KRAS Testing for Treatment of Metastatic Colorectal Cancer L...Patient Views of KRAS Testing for Treatment of Metastatic Colorectal Cancer L...
Patient Views of KRAS Testing for Treatment of Metastatic Colorectal Cancer L...HMO Research Network
 
Comparative Effectiveness of Chemotherapy Regimens for Advanced Lung Cancer C...
Comparative Effectiveness of Chemotherapy Regimens for Advanced Lung Cancer C...Comparative Effectiveness of Chemotherapy Regimens for Advanced Lung Cancer C...
Comparative Effectiveness of Chemotherapy Regimens for Advanced Lung Cancer C...HMO Research Network
 
CER HUB An Informatics Platform for Conducting Compartive Effectiveness with ...
CER HUB An Informatics Platform for Conducting Compartive Effectiveness with ...CER HUB An Informatics Platform for Conducting Compartive Effectiveness with ...
CER HUB An Informatics Platform for Conducting Compartive Effectiveness with ...HMO Research Network
 
An Application of Doubly Robust Estimation JOHNSON
An Application of Doubly Robust Estimation JOHNSONAn Application of Doubly Robust Estimation JOHNSON
An Application of Doubly Robust Estimation JOHNSONHMO Research Network
 
Risk Factors for Short Term Virologic Outcomes Among HIV Infected Patients Un...
Risk Factors for Short Term Virologic Outcomes Among HIV Infected Patients Un...Risk Factors for Short Term Virologic Outcomes Among HIV Infected Patients Un...
Risk Factors for Short Term Virologic Outcomes Among HIV Infected Patients Un...HMO Research Network
 
Expanding SEER Reporting with Comorbidity Data Colorectal Cancer HORNBROOK
Expanding SEER Reporting with Comorbidity Data Colorectal Cancer HORNBROOKExpanding SEER Reporting with Comorbidity Data Colorectal Cancer HORNBROOK
Expanding SEER Reporting with Comorbidity Data Colorectal Cancer HORNBROOKHMO Research Network
 
Drug Characteristics Associated with Medication Adherence Across Eight Diseas...
Drug Characteristics Associated with Medication Adherence Across Eight Diseas...Drug Characteristics Associated with Medication Adherence Across Eight Diseas...
Drug Characteristics Associated with Medication Adherence Across Eight Diseas...HMO Research Network
 
Feasibility of Implementing Screening Brief Intervention and Referral to Trea...
Feasibility of Implementing Screening Brief Intervention and Referral to Trea...Feasibility of Implementing Screening Brief Intervention and Referral to Trea...
Feasibility of Implementing Screening Brief Intervention and Referral to Trea...HMO Research Network
 
eCare for Heart Wellness A Trial to Test the Feasibility of Web Based Dietici...
eCare for Heart Wellness A Trial to Test the Feasibility of Web Based Dietici...eCare for Heart Wellness A Trial to Test the Feasibility of Web Based Dietici...
eCare for Heart Wellness A Trial to Test the Feasibility of Web Based Dietici...HMO Research Network
 
A Telephone Based Diabetes Prevention Program and Social Support for Weight L...
A Telephone Based Diabetes Prevention Program and Social Support for Weight L...A Telephone Based Diabetes Prevention Program and Social Support for Weight L...
A Telephone Based Diabetes Prevention Program and Social Support for Weight L...HMO Research Network
 
Technological Resources & Personnel Costs Required to Implement an Automated ...
Technological Resources & Personnel Costs Required to Implement an Automated ...Technological Resources & Personnel Costs Required to Implement an Automated ...
Technological Resources & Personnel Costs Required to Implement an Automated ...HMO Research Network
 
Online Patient Access to their Medical Record and Health Providers is Associa...
Online Patient Access to their Medical Record and Health Providers is Associa...Online Patient Access to their Medical Record and Health Providers is Associa...
Online Patient Access to their Medical Record and Health Providers is Associa...HMO Research Network
 
Documentations of Advanced Heath Care Directives Where Are They TAI_SEALE
Documentations of Advanced Heath Care Directives Where Are They TAI_SEALEDocumentations of Advanced Heath Care Directives Where Are They TAI_SEALE
Documentations of Advanced Heath Care Directives Where Are They TAI_SEALEHMO Research Network
 

More from HMO Research Network (20)

New Rules Dealing with Conflicts of Interest in Public Health Service Funded ...
New Rules Dealing with Conflicts of Interest in Public Health Service Funded ...New Rules Dealing with Conflicts of Interest in Public Health Service Funded ...
New Rules Dealing with Conflicts of Interest in Public Health Service Funded ...
 
From Populations to Patients
From Populations to PatientsFrom Populations to Patients
From Populations to Patients
 
Evaluation of the Validity of the Gestational Length Assumptions Based Upon A...
Evaluation of the Validity of the Gestational Length Assumptions Based Upon A...Evaluation of the Validity of the Gestational Length Assumptions Based Upon A...
Evaluation of the Validity of the Gestational Length Assumptions Based Upon A...
 
Comparative Safety of Infliximaband Etanercept on the Risk of Serious Infecti...
Comparative Safety of Infliximaband Etanercept on the Risk of Serious Infecti...Comparative Safety of Infliximaband Etanercept on the Risk of Serious Infecti...
Comparative Safety of Infliximaband Etanercept on the Risk of Serious Infecti...
 
A Multi State Markov Model for Analyzing Patterns of Use of Opiod Treatments ...
A Multi State Markov Model for Analyzing Patterns of Use of Opiod Treatments ...A Multi State Markov Model for Analyzing Patterns of Use of Opiod Treatments ...
A Multi State Markov Model for Analyzing Patterns of Use of Opiod Treatments ...
 
A Descriptive Study of Vaccinations Occuring During Pregnancy HENNINGER
A Descriptive Study of Vaccinations Occuring During Pregnancy HENNINGERA Descriptive Study of Vaccinations Occuring During Pregnancy HENNINGER
A Descriptive Study of Vaccinations Occuring During Pregnancy HENNINGER
 
The Use of Administrative Data and Natural Language Processing to Estimate th...
The Use of Administrative Data and Natural Language Processing to Estimate th...The Use of Administrative Data and Natural Language Processing to Estimate th...
The Use of Administrative Data and Natural Language Processing to Estimate th...
 
Patient Views of KRAS Testing for Treatment of Metastatic Colorectal Cancer L...
Patient Views of KRAS Testing for Treatment of Metastatic Colorectal Cancer L...Patient Views of KRAS Testing for Treatment of Metastatic Colorectal Cancer L...
Patient Views of KRAS Testing for Treatment of Metastatic Colorectal Cancer L...
 
Comparative Effectiveness of Chemotherapy Regimens for Advanced Lung Cancer C...
Comparative Effectiveness of Chemotherapy Regimens for Advanced Lung Cancer C...Comparative Effectiveness of Chemotherapy Regimens for Advanced Lung Cancer C...
Comparative Effectiveness of Chemotherapy Regimens for Advanced Lung Cancer C...
 
CER HUB An Informatics Platform for Conducting Compartive Effectiveness with ...
CER HUB An Informatics Platform for Conducting Compartive Effectiveness with ...CER HUB An Informatics Platform for Conducting Compartive Effectiveness with ...
CER HUB An Informatics Platform for Conducting Compartive Effectiveness with ...
 
An Application of Doubly Robust Estimation JOHNSON
An Application of Doubly Robust Estimation JOHNSONAn Application of Doubly Robust Estimation JOHNSON
An Application of Doubly Robust Estimation JOHNSON
 
Risk Factors for Short Term Virologic Outcomes Among HIV Infected Patients Un...
Risk Factors for Short Term Virologic Outcomes Among HIV Infected Patients Un...Risk Factors for Short Term Virologic Outcomes Among HIV Infected Patients Un...
Risk Factors for Short Term Virologic Outcomes Among HIV Infected Patients Un...
 
Expanding SEER Reporting with Comorbidity Data Colorectal Cancer HORNBROOK
Expanding SEER Reporting with Comorbidity Data Colorectal Cancer HORNBROOKExpanding SEER Reporting with Comorbidity Data Colorectal Cancer HORNBROOK
Expanding SEER Reporting with Comorbidity Data Colorectal Cancer HORNBROOK
 
Drug Characteristics Associated with Medication Adherence Across Eight Diseas...
Drug Characteristics Associated with Medication Adherence Across Eight Diseas...Drug Characteristics Associated with Medication Adherence Across Eight Diseas...
Drug Characteristics Associated with Medication Adherence Across Eight Diseas...
 
Feasibility of Implementing Screening Brief Intervention and Referral to Trea...
Feasibility of Implementing Screening Brief Intervention and Referral to Trea...Feasibility of Implementing Screening Brief Intervention and Referral to Trea...
Feasibility of Implementing Screening Brief Intervention and Referral to Trea...
 
eCare for Heart Wellness A Trial to Test the Feasibility of Web Based Dietici...
eCare for Heart Wellness A Trial to Test the Feasibility of Web Based Dietici...eCare for Heart Wellness A Trial to Test the Feasibility of Web Based Dietici...
eCare for Heart Wellness A Trial to Test the Feasibility of Web Based Dietici...
 
A Telephone Based Diabetes Prevention Program and Social Support for Weight L...
A Telephone Based Diabetes Prevention Program and Social Support for Weight L...A Telephone Based Diabetes Prevention Program and Social Support for Weight L...
A Telephone Based Diabetes Prevention Program and Social Support for Weight L...
 
Technological Resources & Personnel Costs Required to Implement an Automated ...
Technological Resources & Personnel Costs Required to Implement an Automated ...Technological Resources & Personnel Costs Required to Implement an Automated ...
Technological Resources & Personnel Costs Required to Implement an Automated ...
 
Online Patient Access to their Medical Record and Health Providers is Associa...
Online Patient Access to their Medical Record and Health Providers is Associa...Online Patient Access to their Medical Record and Health Providers is Associa...
Online Patient Access to their Medical Record and Health Providers is Associa...
 
Documentations of Advanced Heath Care Directives Where Are They TAI_SEALE
Documentations of Advanced Heath Care Directives Where Are They TAI_SEALEDocumentations of Advanced Heath Care Directives Where Are They TAI_SEALE
Documentations of Advanced Heath Care Directives Where Are They TAI_SEALE
 

Incremental Cost Effectiveness of Preventing Depression in At Risk Adolescents DICKERSON

  • 1. Incremental cost-effectiveness of preventing depression in at-risk adolescents John Dickerson, MS May 1, 2012 18th Annual HMO Research Network Conference, Seattle, WA © 2011, KAISER PERMANENTE CENTER FOR HEALTH RESEARCH
  • 2. Frances L. Lynch, PhD John F. Dickerson, MS Greg Clarke, PhD V Robin Weersing, PhD William Beardslee, MD Lynn DeBar, PhD Tracey RG Gladstone, PhD David Brent MD Tami Mark, PhD Giovanna Porta, MS Judy Garber, PhD © 2011, KAISER PERMANENTE CENTER FOR HEALTH RESEARCH
  • 3. Acknowledgements Boston Pittsburgh  Rachel Ammirati  Yuan Brustoloni Satish Iyengar  Jim Cooney  Brian McKain Nadine Melhem  Kate Ginnis  Deena Palenchar Tim Pitts  Mary Kate Little  Jennifer Spendley Ebony West  Ellen Murachver  Nathan Wigham Jamie Zelazny  Shula Ponet  Phyllis Rothberg  Carol Tee Portland Nashville   Kristina Booker Alison Firemark  Mary Jo Coiro Beth Donaghey  Bobbi Jo Yarborough  Laurel Duncan Liz Ezell  Stephanie Hertert  Jocelyn Carter Wendi Marien  Sue Leung  Rachel Swan Matt Morris  Tracy O’Connor  Brandyn Street Sarah Frankel  Kevin Rogers  Katie Gallerani Christian Webb  Jane Wallace  Mi Wu © 2011, KAISER PERMANENTE CENTER FOR HEALTH RESEARCH
  • 4. Adolescent Depression  Point prevalence rates of 3-8%  Average age of first onset = 15 years  Lifetime prevalence rate of depression by end of adolescence = 25%  Relapse rate of 40% within 2 years; 75% within 5 years  Symptoms of depression in adolescence are associated with risk for full-blown disorder  Most cases of recurrent adult depression have initial onsets during adolescence © 2011, KAISER PERMANENTE CENTER FOR HEALTH RESEARCH
  • 5. Consequences of Adolescent Depression – Short Term  Difficulties in relationships  Impaired school and work performance  Increased risk for teen pregnancy  Increased risk for substance abuse  Reduced quality of life  Higher rates of suicide attempts  Higher health care costs  Greater use of school and other social services © 2011, KAISER PERMANENTE CENTER FOR HEALTH RESEARCH
  • 6. Consequences of Adolescent Depression – Long Term  Poor functional outcomes in adulthood  Reduced quality of life  Higher rates of suicide attempts  More psychiatric and medical hospitalizations  Lower educational attainment  More time out of work © 2011, KAISER PERMANENTE CENTER FOR HEALTH RESEARCH
  • 7. Risk Factors for Depression  Parental Depression  Increases risk of youth depression by 40%  Sub-syndromal Depression symptoms  Symptoms but not meeting diagnostic criteria  Increases risk of youth depression by 30%  Previous Episodes of Depression (Weisz et al. 2006; Birmaher & Brent 2007; TADS Team 2004; NICE 2008) © 2011, KAISER PERMANENTE CENTER FOR HEALTH RESEARCH
  • 8. Parental Depression  Strongest risk factor for depression in youth  4X greater risk of depression in children of depressed parents  Amongst adolescents seeking services for depression most have parents with current mood disorders  More internalizing and externalizing disorders, cognitive delays, academic and social difficulties © 2011, KAISER PERMANENTE CENTER FOR HEALTH RESEARCH
  • 9. Treatment of Adolescent Depression  Evidence for pharmacotherapy and psychotherapy (interpersonal psychotherapy, cognitive-behavioral psychotherapy)  Only 25% of youth who meet depression criteria receive any type of treatment  50-60% of those treated in controlled research studies show improvement  Current clinical practice fails to alleviate the majority of the disease burden associated with depression © 2011, KAISER PERMANENTE CENTER FOR HEALTH RESEARCH
  • 10. Prevention and Mental Health  Clinical resources focused on current crises  Researchers and clinicians trained in pathology- based models  Insurance and health care systems designed to provide treatment of disease, prevention is typically less well funded  Most insurance does not currently cover prevention services for mental health © 2011, KAISER PERMANENTE CENTER FOR HEALTH RESEARCH
  • 11. Studies evaluating prevention interventions  Multiple RCT have demonstrated that it is possible to prevent depression episodes using psychotherapeutic interventions including CB approaches  In particular, two studies have demonstrated that a CB Prevention intervention can reduce the risk of depression episodes in youth of depressed parents (Clarke et al. 2001; Lynch et al. 2005; Garber et al. 2010) © 2011, KAISER PERMANENTE CENTER FOR HEALTH RESEARCH
  • 12. Prevention of Depression (POD) Study Specific Aims  To test the efficacy of a cognitive-behavioral (CB) program for preventing depression in at-risk adolescents, across 4 sites  To explore possible moderators  To examine cost-effectiveness of program compared to TAU © 2011, KAISER PERMANENTE CENTER FOR HEALTH RESEARCH
  • 13. Inclusion Criteria  At least one biological parent had a current and/or past depressive episode  Adolescents (13-17 years old) had  Current subsyndromal symptoms of depression [CES-D > 20]  A history of a diagnosed depressive disorder  Or both  Both a selective and indicated sample © 2011, KAISER PERMANENTE CENTER FOR HEALTH RESEARCH
  • 14. Exclusion Criteria  Neither parent nor the teen could be bipolar or schizophrenic  Teens could not  currently meet criteria for MDD or dysthymia  currently be taking any anti-depressant medication  have received cognitive-behavioral therapy © 2011, KAISER PERMANENTE CENTER FOR HEALTH RESEARCH
  • 15. Study Design  RCT  4 sites (Nashville, TN; Boston, MA; Pittsburgh PA; Portland OR)  Adolescents aged 13-17 years  At-risk for depression  316 youth participated in study © 2011, KAISER PERMANENTE CENTER FOR HEALTH RESEARCH
  • 16. POD Prevention Program • Cognitive therapy approach • Groups ranged in size from 3 to 10 • Mixed gender, expected 60-80% female • 8 weekly Acute sessions, 90 minute per session • 6 monthly Continuation sessions, also 90 min’s • Parent group: weeks 1 and 8 (variable attendance) • Led by Master’s level therapists © 2011, KAISER PERMANENTE CENTER FOR HEALTH RESEARCH
  • 17. Methods  Participants assessed at baseline, 3, and 9 months blind to intervention status  Randomized to either CBP or UC  All participants could initiate or continue any health care services, non-health services (e.g., school, social services) © 2011, KAISER PERMANENTE CENTER FOR HEALTH RESEARCH
  • 18. Clinical Outcome Measures  Schedule for Affective Disorders and Schizophrenia for School- Age Children (KSADS) Present and Lifetime Version (Kaufman et al. 1997)  Clinical Global Impression Scale (CGI) - Improvement (Guy 1976)  Child Depression Rating Scale (CDRS) –Revised (Poznanski et al. 1994; Brent et al. 2008). © 2011, KAISER PERMANENTE CENTER FOR HEALTH RESEARCH
  • 19. Clinical Effects for the CEA  Depression Free Days (DFD)  Quality-adjusted Life Years (QALY)  Used clinical data at each assessment  Use linear interpolation between clinical time points  Summed over 9 months © 2011, KAISER PERMANENTE CENTER FOR HEALTH RESEARCH
  • 20. Cost Data  Comprehensive costs of interventions, usual care across service sectors, parent time costs  Collected concurrent with trial  Sources of data  Interviews with study personnel  Study activity and financial records  Child and Adolescent Services Assessment (CASA)  Parent and youth report © 2011, KAISER PERMANENTE CENTER FOR HEALTH RESEARCH
  • 21. Types of Cost Included • Interventions – CBP – Including training and supervision • Usual Care health care  General medical and mental health specialty • Comprehensive services outside Health  Including school, social services, juvenile justice • Family costs  Time, travel © 2011, KAISER PERMANENTE CENTER FOR HEALTH RESEARCH
  • 22. Valuation of resources  Study financial records • Estimated cost of Usual Care services • Unit costs from large databases including MEPS, Marketscan Claims Databases, Previous Studies (Lynch et al. 2005; Lynch et al. 2011; Domino et al. 2008) • Parent and participant reported costs for outside health and other costs • Estimated parent time costs using human capital approach • All resources in 2009 $ © 2011, KAISER PERMANENTE CENTER FOR HEALTH RESEARCH
  • 23. Statistical Analyses  Analyses were intention-to-treat basis  Hypotheses tests from based on group variable in OLS regression models  Bootstrapping with a single model with 1000 replications  (BCa; Thompson et al. 2000; O’Brien & Briggs 2002; O’Brien et al. 1994).  Net benefit regression framework to estimate  Cost Effectiveness Acceptability Curve (CEAC)  Examine differential CE for subgroups indicated by primary clinical analyses (Hoch et al. 2005) © 2011, KAISER PERMANENTE CENTER FOR HEALTH RESEARCH
  • 24. Analyses  Main  All randomized youth  Sensitivity  Alternative QALY weights  Removal of outliers  Sub-group analyses  Based on clinical moderation analyses  Youth whose parents were actively depressed at baseline © 2011, KAISER PERMANENTE CENTER FOR HEALTH RESEARCH
  • 25. Missing Data  Complete clinical outcome and health services data on 87% of participants  Multiple imputation with chained equations (Royston 2004; Royston 2005) using STATA  Assumed missing at random  Included all non-missing values at all time points and baseline demographics in the models  Created five imputation datasets (Little & Rubin 2002) © 2011, KAISER PERMANENTE CENTER FOR HEALTH RESEARCH
  • 26. Table 1 – Sample Description CBP TAU p Adolescents (N=316) n=159 n=157 Age 14.8 (1.5) 14.8 (1.3) .66 Female 93 (58.5%) 92 (58.6%) .98 Caucasian 129 (82.7%) 125 (80.6%) .64 Latino/Hispanic 10 (6.3%) 11 (7.1%) .78 CES-D (entry qualifying score) 18.5 (9.1) 18.8 (9.6) .83 Children’s Depression Rating Scale - 28.6 (8.0) 29.1 (8.5) .52 Revised Household Income 81 (52.3%) 96 (63.6%) .045
  • 27. Incremental Differences in Clinical Outcomes at 9 months  CBP group had:  13 more DFDs (p=.008)  0.022 more QALYs (p=.008)  DFD increased over time for both groups © 2011, KAISER PERMANENTE CENTER FOR HEALTH RESEARCH
  • 28. Table 3. Service Use thru 9 months % with any use Mean use (SD) CBP TAU CBP TAU Inpatient Mental Health Days 1.9 1.3 33.3 (46.5) 11.0 (9.9) Inpatient Alcohol or Drug Days 1.3 0 24.0 (28.3) Counseling or Medication Visits 29.6 27.4 11.3 (17.3) 9.1 (14.3) Day Hospital Days 0.6 0 106 (--) Alcohol or Drug Treatment Visits 1.3 0.6 8.5 (6.4) 33.0 (--) Crisis Services 2.5 0.6 24.0 (34.5) 2.0 (--) Medical doctor visits 6.3 11.5 2.1 (1.5) 1.8 (1.1) Emergency Room Visits 1.9 1.3 1 (--) 2.5 (2.1) 5.7 5.1 Days of Antidepressant Medication 110.9 (78.7) 126.0 (86.5) 3.1 1.9 Days of Stimulant Medication 105.6 (74.2) 61.0 (30.0) Days of Other Psych Medication 0.0 1.3 73.0 (70.4) 153.0 (--) ANY School Services 20.1 22.9 29.1 (61.1) 44.9 (105.2) Juvenile correction contact 1.3 3.2 10.0 (2.8) 5.2 (7.3)
  • 29. Table 4. Cost (2009 USD) thru 9 months CBP TAU CBP TAU Non-Protocol Costs % with Any Cost/ Mean Cost (SD) 52.1 50.3 882 (3,285) 740 (2,021) Family Costs 38.2 36.9 55 (170) 109 (470) Intervention Costs CBP Program Costs 277 (108) Intervention Family costs 314 (200) Total Intervention Costs 591 (286) TOTAL COST 1,579 (4,073) 802 (2,126)
  • 30. Table 5: Adjusted cost effectiveness ratios ICER (95% CI)* DFD QALY Full Sample (n=316) 59 35,434 (11 -263) (6,350 – 157,594) Conservative QALY weight [70%] NA 47,250 (8,706 – 210,125) Excluding cost outlier (n=315) 34 20,417 (2 – 125) (1,193 – 75,188) Excluding patients with ANY 20 12,267 (-1– 76) (-751 –45,581) inpatient utilization (n=308) Outpatient costs only (n=316) 44 26,618 (7 – 192) (4,063 – 115,461) Parental depression** Dominated Dominated No parental depression 14 8,683 (-7 – 42) (-4,157–25,156) *. bias corrected; **. CBP never preferred for this group.
  • 31. Figure 1. Cost-effectiveness Planes Base Case CDRS-DFDs -- through month 8 $2,000 Higher cost, better outcome Higher cost, worse outcome Incremental Total Cost $1,000 $0 -$1,000 -$2,000 Lower cost, worse outcome Lower cost, better outcome -40 -30 -20 -10 0 10 20 30 40 Incremental Change in CDRS-DFD 1000 replications; adjusted for age, baseline costs, race, household income, and gender differences © 2011, KAISER PERMANENTE CENTER FOR HEALTH RESEARCH
  • 32. Figure 2. Cost-effectiveness acceptability curve base case QALY (CDRS-DFD-based) at Month 8 100% Probability Treatment is Cost-Effective 75% 50% 25% 0% $0 $50,000 $100,000 $150,000 $200,000 $300,000 $400,000 $500,000 Willingness to Pay © 2011, KAISER PERMANENTE CENTER FOR HEALTH RESEARCH
  • 33. Figure 3. Cost-effectiveness planes by subgroup No Parental Depression at Baseline Parental Depression at Baseline $4,000 $4,000 Higher cost, worse outcome Higher cost, worse outcome Higher cost, better outcome Higher cost, better outcome $2,000 $2,000 Incremental Total Cost Incremental Total Cost $1,000 $1,000 $0 $0 -$1,000 -$1,000 -$2,000 -$2,000 Lower cost, better outcome Lower cost, better outcome Lower cost, worse outcome =$4,000 =$4,000 Lower cost, worse outcome -40 -30 -20 -10 0 10 20 30 40 -40 -30 -20 -10 0 10 20 30 40 Incremental Change in CDRS-DFD Incremental Change in CDRS-DFD 1000 replications; adjusted for age, baseline costs, race, household income, and gender differences 1000 replications; adjusted for age, baseline costs, race, household income, and gender differences © 2011, KAISER PERMANENTE CENTER FOR HEALTH RESEARCH
  • 34. Figure 4. Cost-effectiveness acceptability curves by subgroup No Parental Depression at Baseline Parental Depression at Baseline 100% 100% 75% 75% Probability Treatment is Cost-Effective Probability Treatment is Cost-Effective 50% 50% 25% 25% 0% 0% $0 $50,000 $100,000 $150,000 $200,000 $300,000 $400,000 $500,000 $0 $50,000 $100,000 $150,000 $200,000 $300,000 $400,000 $500,000 Willingness to Pay Willingness to Pay © 2011, KAISER PERMANENTE CENTER FOR HEALTH RESEARCH
  • 35. Preliminary Conclusions  CBP increased DFD and QALYs  CBP significantly more expensive  CBP is very likely to be cost-effective compared to many medical services currently covered by most insurance programs  CBP highly cost-effective for youth whose parent’s depression was in REMISSION at baseline © 2011, KAISER PERMANENTE CENTER FOR HEALTH RESEARCH
  • 36. Limitations  Did not include productivity costs for youth  Adult literature suggests productivity is the largest cost of depression  Suggests substantial lost time from school  Did not include all family costs  Included typical parent time costs  Did NOT include caregiving time, coordination, other  Methods for calculating QALYs  Followed standard methods, but did not directly measure utility weights  No utility weights in youth available – used adult weights  Weights do not account for comorbidity © 2011, KAISER PERMANENTE CENTER FOR HEALTH RESEARCH
  • 37. Future Directions  Replication over longer period of time  Clinical outcomes and costs may change over time  Data are collected through 32 months  Need better information on sub-groups  Larger sample could help to understand moderation of clinical and cost outcomes  May need to adapt interventions for some risk groups  Co-treatment of parent and youth, sequential treatment of parent and youth  Need for Preference Based HRQL in youth  Evidence that depression negatively affects HRQL in youth  No preference based QALY weights for youth © 2011, KAISER PERMANENTE CENTER FOR HEALTH RESEARCH